{
    "id": 16552,
    "fullName": "TP53 S241F",
    "impact": "missense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "TP53 S241F lies within the DNA-binding domain of the Tp53 protein (PMID: 22713868). S241F results in a decreased in Tp53 transcriptional activity (PMID: 19225112, PMID: 26585234), and interferes with formation of the Tp53/Bard1/CstF complex in cell culture (PMID: 21383700).",
            "references": [
                {
                    "id": 4333,
                    "pubMedId": 19225112,
                    "title": "A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19225112"
                },
                {
                    "id": 2397,
                    "pubMedId": 22713868,
                    "title": "Mutant p53: one name, many proteins.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22713868"
                },
                {
                    "id": 4334,
                    "pubMedId": 21383700,
                    "title": "p53 inhibits mRNA 3' processing through its interaction with the CstF/BARD1 complex.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21383700"
                },
                {
                    "id": 7588,
                    "pubMedId": 26585234,
                    "title": "Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26585234"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7157,
        "geneSymbol": "TP53",
        "terms": [
            "TP53",
            "BCC7",
            "BMFS5",
            "LFS1",
            "P53",
            "TRP53"
        ]
    },
    "variant": "S241F",
    "createDate": "01/14/2016",
    "updateDate": "09/19/2018",
    "referenceTranscriptCoordinates": {
        "id": 95670,
        "transcript": "NM_000546",
        "gDna": "chr17:g.7674241G>A",
        "cDna": "c.722C>T",
        "protein": "p.S241F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5015,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Ganetespib inhibited growth of human ovarian cancer cells harboring TP53 S241F in culture (PMID: 26009011).",
            "molecularProfile": {
                "id": 16831,
                "profileName": "TP53 S241F"
            },
            "therapy": {
                "id": 745,
                "therapyName": "Ganetespib",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4831,
                    "pubMedId": 26009011,
                    "title": "Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26009011"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10547,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, an ovarian clear cell adenocarcinoma cell line harboring TP53 S241F demonstrated reduced sensitivity to DS-7423 in culture (PMID: 24504419).",
            "molecularProfile": {
                "id": 16831,
                "profileName": "TP53 S241F"
            },
            "therapy": {
                "id": 722,
                "therapyName": "DS-7423",
                "synonyms": null
            },
            "indication": {
                "id": 5304,
                "name": "ovarian clear cell adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 4912,
                    "pubMedId": 24504419,
                    "title": "Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24504419"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 8283,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, APR-246 demonstrated efficacy in xenograft models of small cell lung cancer harboring TP53 S241F (PMID: 21415220).",
            "molecularProfile": {
                "id": 16831,
                "profileName": "TP53 S241F"
            },
            "therapy": {
                "id": 1946,
                "therapyName": "APR-246",
                "synonyms": null
            },
            "indication": {
                "id": 5409,
                "name": "lung small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 2429,
                    "pubMedId": 21415220,
                    "title": "PRIMA-1Met/APR-246 induces apoptosis and tumor growth delay in small cell lung cancer expressing mutant p53.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21415220"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8266,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, NSC59984 induced Tp53 pathway signaling, degradation of mutant Tp53, and cell death in a colorectal cancer (CRC) cell line harboring TP53 S241F, and inhibited tumor growth in TP53 S241F-mutant CRC cell line xenograft models, in a TP73 dependent manner (PMID: 26294215).",
            "molecularProfile": {
                "id": 26214,
                "profileName": "TP53 S241F TP73 pos"
            },
            "therapy": {
                "id": 3402,
                "therapyName": "NSC59984",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4303,
                    "pubMedId": 26294215,
                    "title": "Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26294215"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8564,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Sapanisertib (MLN0128) and PD-0325901 synergistically inhibited Erk and PI3K signaling and proliferation, but did not induce apoptosis in colorectal cancer cells harboring KRAS G13D, PIK3CA E545K, and TP53 S241F in culture (PMID: 26272063).",
            "molecularProfile": {
                "id": 26357,
                "profileName": "KRAS G13D PIK3CA E545K TP53 S241F"
            },
            "therapy": {
                "id": 4771,
                "therapyName": "PD-0325901 + Sapanisertib",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6689,
                    "pubMedId": 26272063,
                    "title": "MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26272063"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 16831,
            "profileName": "TP53 S241F",
            "profileTreatmentApproaches": [
                {
                    "id": 7394,
                    "name": "p53 Gene Therapy",
                    "profileName": "TP53 S241F"
                },
                {
                    "id": 7393,
                    "name": "p53 Activator",
                    "profileName": "TP53 S241F"
                }
            ]
        },
        {
            "id": 26214,
            "profileName": "TP53 S241F TP73 pos",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 26357,
            "profileName": "KRAS G13D PIK3CA E545K TP53 S241F",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 95671,
            "transcript": "NM_001126113",
            "gDna": "chr17:g.7674241G>A",
            "cDna": "c.722C>T",
            "protein": "p.S241F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 95672,
            "transcript": "NM_001126114",
            "gDna": "chr17:g.7674241G>A",
            "cDna": "c.722C>T",
            "protein": "p.S241F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 95669,
            "transcript": "NM_001126112",
            "gDna": "chr17:g.7674241G>A",
            "cDna": "c.722C>T",
            "protein": "p.S241F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 95670,
            "transcript": "NM_000546",
            "gDna": "chr17:g.7674241G>A",
            "cDna": "c.722C>T",
            "protein": "p.S241F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}